Other Updated 2023-01-17

EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance to specific SARS-CoV-2 Subvariants

Recalled Product

EVUSHELD (tixagevimab and cilgavimab for injection)


Hazard / Issue

New safety information - Product safety - COVID

Issued by

Marketed health products

View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon Canada →